Want to see JP:3671 full AI Analyst Report?
3671 Stock Chart & Stats
¥334.00
¥0.00(0.00%)
At close: 4:00 PM EST
¥334.00
¥0.00(0.00%)
Day’s Range― - ―
52-Week Range¥270.00 - ¥416.00
Previous CloseN/A
Volume5.20K
Average Volume (3M)23.83K
Market Cap
¥7.31B
Enterprise Value¥6.62K
Total Cash (Recent Filing)¥2.77B
Total Debt (Recent Filing)¥2.44B
Price to Earnings (P/E)14.4
Beta0.53
Next Earnings
Nov 09, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.22%
Share Statistics
EPS (TTM)21.54
Shares Outstanding24,050,800
10 Day Avg. Volume10,650
30 Day Avg. Volume23,826
Financial Highlights & Ratios
PEG Ratio0.73
Price to Book (P/B)2.04
Price to Sales (P/S)1.16
P/FCF Ratio20.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Healthcare-focused Recurring Revenue ModelSpecialization in hospital and clinical IT creates durable demand and high customer retention: implementation projects plus ongoing maintenance/support generate recurring service revenue and switching frictions. This business model supports steadier cash flows and long-term client relationships versus one-off software sales.
Consistent Historical ProfitabilitySteady net and EBIT margins over multiple years indicate structural pricing power and operational efficiency in a niche market. Consistent profitability provides resilience through cyclicality, funds reinvestment and dividends, and underpins the company’s ability to sustain operations while pursuing product/support enhancements.
High Free Cash Flow Conversion To EarningsVery strong FCF-to-net-income conversion signals earnings quality and real cash generation ability. Reliable free cash supports shareholder returns, reinvestment in product development and services, and provides a buffer to manage leverage or fund targeted growth without immediate equity raises.
Bears Say
Sharp 2025 Revenue DeclineA 22% revenue drop in the latest year is a meaningful structural setback that can erode scale advantages, reduce recurring maintenance base, and limit reinvestment. If sustained, lower revenue makes fixed-cost absorption harder and raises execution risk for restoring growth in a competitive healthcare IT market.
Rising LeverageHigher debt-to-equity shifts the company’s capital structure toward greater financial risk. With earnings volatility and recent revenue weakness, elevated leverage reduces flexibility for strategic investments, increases interest burden sensitivity, and narrows the margin for error during recovery periods.
Weaker Operating Cash Flow In 2025A marked drop in operating cash flow undermines liquidity even if FCF tracks net income historically. Lower OCF constrains the company’s ability to fund working capital, invest in product/service upgrades, and shore up margins without relying on borrowing, which is problematic amid the recent revenue contraction.
3671 FAQ
What was Softmax Co., Ltd. (Japan)’s price range in the past 12 months?
Softmax Co., Ltd. (Japan) lowest stock price was ¥270.00 and its highest was ¥416.00 in the past 12 months.
What is Softmax Co., Ltd. (Japan)’s market cap?
Softmax Co., Ltd. (Japan)’s market cap is ¥7.31B.
When is Softmax Co., Ltd. (Japan)’s upcoming earnings report date?
Softmax Co., Ltd. (Japan)’s upcoming earnings report date is Nov 09, 2026 which is in 54 days.
How were Softmax Co., Ltd. (Japan)’s earnings last quarter?
Softmax Co., Ltd. (Japan) released its earnings results on Aug 12, 2026. The company reported ¥3.36 earnings per share for the quarter.
Is Softmax Co., Ltd. (Japan) overvalued?
According to Wall Street analysts Softmax Co., Ltd. (Japan)’s price is currently Overvalued.
Does Softmax Co., Ltd. (Japan) pay dividends?
Softmax Co., Ltd. (Japan) pays a Annually dividend of ¥10 which represents an annual dividend yield of 3.22%. See more information on Softmax Co., Ltd. (Japan) dividends here
What is Softmax Co., Ltd. (Japan)’s EPS estimate?
Softmax Co., Ltd. (Japan)’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Softmax Co., Ltd. (Japan) have?
Softmax Co., Ltd. (Japan) has 24,050,800 shares outstanding.
What happened to Softmax Co., Ltd. (Japan)’s price movement after its last earnings report?
Softmax Co., Ltd. (Japan) reported an EPS of ¥3.36 in its last earnings report. Following the earnings report the stock price went up 1.948%.
Which hedge fund is a major shareholder of Softmax Co., Ltd. (Japan)?
Currently, no hedge funds are holding shares in JP:3671
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Softmax Co., Ltd. (Japan)
Softmax Co., Ltd handles the complete spectrum of corporate system services, encompassing their development, commercialization, deployment, and ongoing support. A significant portion of their work is dedicated to creating advanced medical information systems. Their offerings within the healthcare sector are diverse, comprising web-based electronic medical record (EMR) systems, online patient ordering platforms, medical financial management software, radiology information systems, and specialized solutions for rehabilitation departments, health screening, nursing task management, and surgical units. Established in 1974, Softmax Co., Ltd's corporate headquarters are located in Tokyo, Japan.